Some studies have found that Acads are downregulated in cancer cells and expression levels are correlated with clinical cancer stage and predict patient prognosis [43], but the different expression change in Acads observed in our study may be related to the benign properties of the relatively young adenomas we analyzed at the later time points in this study. The gene discussed is ACADS; the disease is cancer.